Search results for "second quarter"

Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter, but their bottom lines diverged...
Samsung Biologics Posts 586.4 Billion Won Q2 Profit, But Labor Uncertainty Looms

Samsung Biologics Posts 586.4 Billion Won Q2 Profit, But Labor Uncertainty Looms

Samsung Biologics reported second-quarter revenue in the 1. 3 trillion won range this year, a 30% increase from the same period last year.
AI Generates and Self-Checks Specialist Study Materials—Yet 1% Still Contain Critical Errors

AI Generates and Self-Checks Specialist Study Materials—Yet 1% Still Contain Critical Errors

Artificial intelligence can now generate study materials for medical specialist board exams and run automated checks...
Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars

Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars

Celltrion is consolidating its leading market position across major Asian countries with its key autoimmune and...
Celltrion Chairman Seo Jung-jin Forgoes Summer Vacation for Global Business Tour Targeting Record Second Half

Celltrion Chairman Seo Jung-jin Forgoes Summer Vacation for Global Business Tour Targeting Record Second Half

Celltrion Group Chairman Seo Jung-jin will forgo his summer vacation this August to embark on an intensive overseas...
Sales Rise 11%, but Chong Kun Dang’s Q2 Operating Profit Slips 10%

Sales Rise 11%, but Chong Kun Dang’s Q2 Operating Profit Slips 10%

Chong Kun Dang posted higher sales in the second quarter of this year, but its operating profit fell 10% from a year...
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%

Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%

Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
117 Workplace Accidents Recognized at 25 Major Korean Pharma and Biotech Firms Over Five Years

117 Workplace Accidents Recognized at 25 Major Korean Pharma and Biotech Firms Over Five Years

A review of 25 major South Korean pharmaceutical and biotechnology companies revealed 117 recognized industrial...
Samsung Biologics Labor Dispute Set for Limited Q2 Impact, but Second-Half Outlook Hinges on Union Deal and U.S. Plant Costs

Samsung Biologics Labor Dispute Set for Limited Q2 Impact, but Second-Half Outlook Hinges on Union Deal and U.S. Plant Costs

With wage and collective bargaining talks between Samsung Biologics and its union still unresolved, analysts expect...